Top Story

State of the science: High-priority transplant trials for nonmalignant disease

State of the science: High-priority transplant trials for nonmalignant disease
HemOnc Today, April 25, 2015
Hemant Murthy, MD; William Wood, MD

Last June, we launched a series of columns in HemOnc Today intended to discuss high-priority proposals that emerged from the 2014 Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium.

The State of the Science Symposium (SOSS), which started in 2001 and is held every 7 years, highlights the challenges and research priorities facing hematopoietic cell transplantation.

In the Journals

HSCT associated with increased risk for fractures

April 24, 2015
Patients who underwent hematopoietic stem cell transplantation had a considerably higher incidence of fractures compared with the general population, according to…
Meeting News Coverage

HBV reactivation prevalent after hematopoietic stem cell transplant

April 24, 2015
VIENNA — Hepatitis B virus infection reactivation was prevalent in treatment-naive patients undergoing hematopoietic stem cell transplantation, according to data…
Richard J. O’Reilly, MD Meeting News CoveragePerspective

T-cell immunotherapy appears effective in post-HSCT lymphoproliferative disorder

April 20, 2015
PHILADELPHIA — A new type of T cell-based immunotherapy induced response in a majority of patients with Epstein-Barr virus-associated lymphoproliferative disorder…
CME CNE
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
4115430797001 th

Reduced-intensity, related haploidentical transplantation tolerable among older patients

December 8, 2013
NEW ORLEANS — Yvette Kasamon, MD, associate professor of oncology and medicine at the Sidney Kimmel…
More »
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
Hemant Murthy, MD In PracticePublication Exclusive

State of the science: High-priority transplant trials for nonmalignant disease

HemOnc Today, April 25, 2015
Hemant Murthy, MD; William Wood, MD
Last June, we launched a series of columns in HemOnc Today intended to discuss high-priority proposals that emerged from the 2014 Blood and Marrow…
In the Journals

HSCT associated with increased risk for fractures

April 24, 2015
Patients who underwent hematopoietic stem cell transplantation had a considerably higher incidence of fractures compared with the general population…
Meeting News Coverage

HBV reactivation prevalent after hematopoietic stem cell transplant

April 24, 2015
VIENNA — Hepatitis B virus infection reactivation was prevalent in treatment-naive patients undergoing hematopoietic stem cell transplantation…
Richard J. O’Reilly, MD Meeting News CoveragePerspective

T-cell immunotherapy appears effective in post-HSCT lymphoproliferative disorder

April 20, 2015
PHILADELPHIA — A new type of T cell-based immunotherapy induced response in a majority of patients with Epstein-Barr virus-associated…
In the Journals

Respiratory virus infection before HCT increases mortality

April 17, 2015
Routine testing for respiratory viruses before hematopoietic cell transplantation is reasonable in symptomatic patients and transplantation should…
In the Journals

HSCT outcomes similar in pediatric ALL regardless of donor type

April 6, 2015
 Pediatric patients with high-risk acute lymphoblastic leukemia who underwent hematopoietic stem cell transplantation with matched unrelated…
Michael Boeckh In the Journals

Antivirals improve CMV pneumonia outcomes after HCT

March 30, 2015
Outcomes of cytomegalovirus pneumonia after hematopoietic cell transplantation have improved modestly over the past 25 years largely due to…
In the JournalsPerspective

HSCT access limited by country, cost

March 23, 2015
Although the number of hematopoietic stem cell transplants performed worldwide reached 1 million in 2012, the procedure is primarily utilized by…
In the Journals

Donor leukocyte telomere length linked to transplantation outcomes in aplastic anemia

February 10, 2015
Longer donor leukocyte telomere length was associated with improved survival in patients with severe aplastic anemia who underwent allogeneic…
Christopher Röllig, MD In the Journals

Allogeneic HSCT prolonged RFS in NPM1-mutated AML

February 4, 2015
Allogeneic hematopoietic stem cell transplantation was associated with significantly improved RFS in patients with acute myeloid leukemia who…
More Headlines »
morganatic-roan